BICL leaders are present at OARSI 2022 Conference in Berlin!
BICL, the leading imaging provider in Osteoarthritis Clinical Trials and Academic Clinical Studies, is a sponsor of the World Congress on Osteoarthrtis upcoming in Berlin from April 07-10.
BICL leaders are present at the upcoming OARSI Meeting. Please do not miss:
Dr. Guermazi will be presenting on subchondral bone marrow lesions in the Pre-Congress Workshop “Characterizing Bone Marrow Lesions in Osteoarthritis” together with leading scientists Dr. David Hunter, Dr. Nidhi Sofat and Dr. David Walsh. The title of Dr. Guerazi’s presentation is “Bone marrow lesions by Magnetic Resonance Imaging: The MOAKS score”.
Dr. Roemer as one of the main program organizers ad will be chairing several sessions including the concurrent sessions Imaging, Therapeutic Challenges in OA and Year in Review.
Please visit us at the poster hall on Friday April 8 and Saturday April 9 from 3:30 pm-5 pm!
BICL will have the following posters on display:
Poster # 72: TECHNICAL SUCCESS RATE OF INTRA-ARTICULAR KNEE INJECTION- COMPARISON BETWEEN ULTRASOUND-GUIDED AND PALPATION-GUIDED INJECTION USING RADIOGRAPHIC DEPICTION OF INTRA-ARTICULAR AIR CONTRAST AS A REFERENCE. Guermazi A, et al.
Poster # 323: SEMI-QUANTITATIVE AND QUANTITATIVE CARTILAGE IMPROVEMENT AFTER INTRA-ARTICULAR INJECTION OF ICM-203 IN CANINE OA MODEL. Guermazi A, et al.
Poster #355: MRI-ASSESSED INCREASE IN GRADE AND EXTENT OF SUBREGIONAL INVOLVEMENT OF MENISCAL DAMAGE AND BONE MARROW LESIONS DEFINED SEMI-QUANTITATIVELY ARE ASSOCIATED WITH CONCURRENT QUANTITATIVELY-DEFINED CARTILAGE THICKNESS LOSS: THE FNIH BIOMARKERS CONSORTIUM STUDY. Roemer FW et al.
Poster #356: MRI UNDERESTIMATES PRESENCE AND SIZE OF KNEE OSTEOPHYTES USING CT AS A REFERENCE STANDARD. Roemer FW et al.
Poster # 358: KELLGREN-LAWRENCE 2 AND 3 KNEES WITH A CARTILAGE-MENISCUS PHENOTYPE SHOW DIFFERENT PATTERNS OF STRUCTRAL PROGRESSION. Roemer FW et al.
Poster # 359: NON-CARTILAGINOUS STRUCTURAL JOINT DAMAGE AS ASSESSED BY MRI INCREASES RATES OF QUANTITATIVE MRI-DETECTED CARTILAGE THICKNESS LOSS OVER 24 MONTHS: THE APPROACH STUDY. Roemer FW et al.
Poster # 360: RELEVANCE OF WITHIN-GRADE CARTILAGE ASSESSMENT USING THE MOAKS SCORING INSTRUMENT AND CORRESPONDING QUANTITATIVE CARTILAGE THICKNESS LOSS: DATA FROM THE OAI FNIH BIOMARKERS CONSORTIUM STUDY. Roemer FW et al.